Towa Pharmaceutical Co., Ltd.
4553.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥5,701 | ¥2,513 | ¥4,362 | ¥8,069 |
| Dep. & Amort. | ¥5,657 | ¥5,249 | ¥5,337 | ¥5,162 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥2,022 | -¥1,647 | ¥8,008 | -¥18,395 |
| Other Non-Cash | -¥1,136 | -¥223 | -¥1 | ¥2,205 |
| Operating Cash Flow | ¥8,200 | ¥5,892 | ¥17,706 | -¥2,959 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥8,970 | -¥4,380 | -¥7,601 | -¥10,341 |
| Net Acquisitions | ¥0 | ¥0 | ¥9 | ¥0 |
| Inv. Purchases | -¥1,240 | ¥0 | -¥203 | ¥0 |
| Inv. Sales/Matur. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Inv. Act. | -¥43 | -¥337 | ¥381 | -¥1,088 |
| Investing Cash Flow | -¥10,253 | -¥4,717 | -¥7,414 | -¥11,429 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥1,896 | ¥7,178 | ¥6,046 | ¥2,847 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | ¥0 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | -¥89 | -¥1,878 | -¥61 | -¥1,469 |
| Other Fin. Act. | -¥8 | ¥953 | ¥0 | ¥1 |
| Financing Cash Flow | -¥1,993 | ¥6,253 | ¥5,985 | ¥1,379 |
| Forex Effect | -¥579 | ¥49 | -¥68 | ¥1,013 |
| Net Chg. in Cash | -¥4,625 | ¥7,477 | ¥16,209 | ¥29,231 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥52,938 | ¥45,461 | ¥29,252 | ¥0 |
| End Cash | ¥48,313 | ¥52,938 | ¥45,471 | ¥29,231 |
| Free Cash Flow | -¥223 | ¥1,512 | ¥10,879 | -¥13,300 |